Stryker SYK
NYSE SYK
$275.50 -0.93 (-0.34%)
As of: Sep 9, 2026 · 3:59 PM EDT

Stryker (SYK) Cash & Current Investments (2009 - 2026)

Stryker's (SYK) quarterly Cash & Current Investments came in at $3.5 billion in Q2 2026, up 41.07% year-over-year from $2.5 billion in Q2 2025, and up 17.23% quarter-over-quarter from $3.0 billion in Q1 2026.

Analysis

Stryker (SYK) Cash & Current Investments (2009 - 2026) Analysis & Trends

Stryker (SYK) has reported Cash & Current Investments for 18 consecutive years, with $3.5 billion the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Cash & Current Investments rose 41.07% year-over-year to $3.5 billion in Q2 2026; TTM through Jun 2026 was $3.5 billion, a 41.07% increase from a year earlier, with the FY2025 full-year figure at $4.1 billion, down 6.86% from the prior year.
  • Cash & Current Investments was $3.5 billion for Q2 2026 at Stryker, up from $3.0 billion in the prior quarter.
  • Over five years, Cash & Current Investments peaked at $4.6 billion in Q3 2024 and troughed at $1.1 billion in Q2 2022.
  • A 5-year average of $2.6 billion and a median of $2.4 billion in 2024 frame the typical range for Cash & Current Investments.
  • Across the five-year window, Cash & Current Investments plunged 51.53% in 2022 and jumped 137.6% in 2024, its largest moves.
  • Over 5 years, Cash & Current Investments stood at $1.9 billion in 2022, then jumped by 58.35% to $3.1 billion in 2023, then jumped by 44.19% to $4.4 billion in 2024, then fell by 6.86% to $4.1 billion in 2025, then fell by 15.22% to $3.5 billion in 2026.
  • The last three Cash & Current Investments figures came in at $3.5 billion (Q2 2026), $3.0 billion (Q1 2026), and $4.1 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn 5.60 Bn
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn 5.22 Bn
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn 8.82 Bn
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn 3.48 Bn
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn 539.00 Mn
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn 4.25 Bn
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn 1.46 Bn
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn 1.95 Bn
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn 482.30 Mn
10 Zimmer Biomet Holdings 18.20 Bn 17.79 Bn 1.54 Bn 410.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.48 Bn
Mar 31, 2026 2.97 Bn
Dec 31, 2025 4.10 Bn
Sep 30, 2025 3.34 Bn
Jun 30, 2025 2.46 Bn
Mar 31, 2025 2.41 Bn
Dec 31, 2024 4.40 Bn
Sep 30, 2024 4.60 Bn
Jun 30, 2024 1.96 Bn
Mar 31, 2024 2.41 Bn
Dec 31, 2023 3.05 Bn
Sep 30, 2023 1.94 Bn
Jun 30, 2023 1.48 Bn
Mar 31, 2023 1.76 Bn
Dec 31, 2022 1.93 Bn
Sep 30, 2022 1.50 Bn
Jun 30, 2022 1.13 Bn
Mar 31, 2022 1.53 Bn
Dec 31, 2021 3.02 Bn
Sep 30, 2021 2.64 Bn